Showing 65,241 - 65,260 results of 152,619 for search '(( a we decrease ) OR ( 5 ((wt decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.27s Refine Results
  1. 65241

    Characteristics of the 280 VOCs at inclusion. by Mohamed Condé (22622306)

    Published 2025
    “…<div><p>Acute chest syndrome (ACS) is a life-threatening complication of sickle cell anemia (SCA). …”
  2. 65242

    S1 Graphical abstract - by Hai Nguyen Ngoc Dang (19200560)

    Published 2024
    “…A longer diabetes duration was linked to a greater ASI (r = 0.43, p < 0.05), while the AS decreased (r = -0.37, p < 0.05).…”
  3. 65243
  4. 65244

    Table1_Fine tuning a logical model of cancer cells to predict drug synergies: combining manual curation and automated parameterization.DOCX by Åsmund Flobak (789984)

    Published 2023
    “…<p>Treatment with combinations of drugs carries great promise for personalized therapy for a variety of diseases. We have previously shown that synergistic combinations of cancer signaling inhibitors can be identified based on a logical framework, by manual model definition. …”
  5. 65245

    Supplementary Material for: Low-Dose Alcohol-Induced Inhibition of Mouse Orthotopically Transplanted Tumors Is Associated with T-Cell Response by Kimoto A. (12549820)

    Published 2022
    “…This study examined the effects of low-dose alcohol (0.5%, 1%, and 2%) on tumor growth in a transplant colon cancer model. …”
  6. 65246

    Schematic summary of P2RX7 in NASH-affected livers and effects of P2RX7 pharmacological inhibition <i>in vitro</i> and <i>in vivo</i>. by Bernat Baeza-Raja (8928026)

    Published 2020
    “…<p>NASH-affected livers show greater number of cells expressing P2RX7, NLRP3 inflammasome activation, IL-1β, CCL2/CCL5 and fibrosis. P2RX7 is expressed by infiltrating MOs and resident KCs in the livers of NASH-affected individuals. …”
  7. 65247

    S3 File - by Abdullah Niaz (16955618)

    Published 2023
    “…At higher concentrations some desorption was observed (36% at 50 ppm) but was reduced at lower concentrations (1–3% at < 5 ppm). Desorption decreased with increasing pyrolysis temperature. …”
  8. 65248

    Plant Extracellular Nanovesicle-Loaded Hydrogel for Topical Antibacterial Wound Healing <i>In Vivo</i> by Saroj Saroj (13749336)

    Published 2024
    “…MENV-HG was topically applied on wounds with a slow MENV release profile, ensuring effective healing. …”
  9. 65249

    S1 File - by Abdullah Niaz (16955618)

    Published 2023
    “…At higher concentrations some desorption was observed (36% at 50 ppm) but was reduced at lower concentrations (1–3% at < 5 ppm). Desorption decreased with increasing pyrolysis temperature. …”
  10. 65250

    Key properties of MCPA. by Abdullah Niaz (16955618)

    Published 2023
    “…At higher concentrations some desorption was observed (36% at 50 ppm) but was reduced at lower concentrations (1–3% at < 5 ppm). Desorption decreased with increasing pyrolysis temperature. …”
  11. 65251

    Plant Extracellular Nanovesicle-Loaded Hydrogel for Topical Antibacterial Wound Healing <i>In Vivo</i> by Saroj Saroj (13749336)

    Published 2024
    “…MENV-HG was topically applied on wounds with a slow MENV release profile, ensuring effective healing. …”
  12. 65252

    S2 File - by Abdullah Niaz (16955618)

    Published 2023
    “…At higher concentrations some desorption was observed (36% at 50 ppm) but was reduced at lower concentrations (1–3% at < 5 ppm). Desorption decreased with increasing pyrolysis temperature. …”
  13. 65253
  14. 65254

    Data_Sheet_1_A de novo GRIN1 Variant Associated With Myoclonus and Developmental Delay: From Molecular Mechanism to Rescue Pharmacology.pdf by Jin Zhang (53297)

    Published 2021
    “…<p>N-Methyl-D-aspartate receptors (NMDARs) are highly expressed in brain and play important roles in neurodevelopment and various neuropathologic conditions. Here, we describe a new phenotype in an individual associated with a novel de novo deleterious variant in GRIN1 (c.1595C>A, p.Pro532His). …”
  15. 65255

    Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation by Firas Alhasson (3853897)

    Published 2017
    “…Altered microbiome caused significant decrease in tight junction protein Occludin with a concomitant increase in Claudin-2, a signature of a leaky gut. …”
  16. 65256

    Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe by A. T. Makadzange (836991)

    Published 2015
    “…In children, nevirapine based ART regimen was associated with a 3-fold increased risk of failure (AOR: 3.5; 95% CI: 1.3, 9.1, p = 0.0180). …”
  17. 65257

    The mechanism underlying autophagy impairment in hepatic G6Pase-α-deficiency. by Jun-Ho Cho (4053676)

    Published 2017
    “…Impaired SIRT1 signaling increases ATG acetylation and decreases ATG12-ATG5 conjugation along with downregulation of FoxO signaling that induces autophagy genes. …”
  18. 65258

    Table_1_Trend of pregnancy outcomes in type 1 diabetes compared to control women: a register-based analysis in 1996-2018.docx by Vince Fazekas-Pongor (16531365)

    Published 2023
    “…</p>Methods<p>We used anonymized records of a mandatory nation-wide registry of all deliveries between gestational weeks 24 and 42 in Hungary. …”
  19. 65259

    Representative photomicrographs and densitometrical quantification of PPARα (A–D), NAAA (E–H), NAPE-PLD (I–L) and FAAH (M–P) immunoreactivity in human healthy (control; A, E, I, M)... by Juan Suárez (161921)

    Published 2012
    “…<p>Active UC at disease onset showed a decrease in PPARα and NAPE-PLD immunoreactivity, but an increase in NAAA immunoreactivity. …”
  20. 65260

    Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines-2 by Anna Tesei (11122)

    Published 2011
    “…<p><b>Copyright information:</b></p><p>Taken from "Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines"</p><p>http://www.translational-medicine.com/content/5/1/52</p><p>Journal of Translational Medicine 2007;5():52-52.…”